Profile
Maud Brandely worked as the Director of Oncology Clinical Development at Pierre Fabre SA and as the Director of Taxotere Clinical Development at Rhone-Poulenc SA. From 2016 to 2024, Dr. Brandely served as the Chief Medical Officer & VP of Medical Affairs at Transgene SA. Dr. Brandely obtained a graduate and doctorate degree from Université Pierre et Marie Curie.
Former positions of Maud Brandely
| Companies | Position | End |
|---|---|---|
| TRANSGENE | Chief Tech/Sci/R&D Officer | 2024-09-09 |
Pierre Fabre SA
Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Corporate Officer/Principal | 2016-01-31 |
Rhone-Poulenc SA
Rhone-Poulenc SA Chemicals: SpecialtyProcess Industries Manufactures and supplies chemicals | Corporate Officer/Principal | - |
Training of Maud Brandely
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Pierre Fabre SA
Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Health Technology |
Rhone-Poulenc SA
Rhone-Poulenc SA Chemicals: SpecialtyProcess Industries Manufactures and supplies chemicals | Process Industries |
Université Pierre et Marie Curie
Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Maud Brandely
















